Helix Acquisition Corp.
Status: Closed Deal
U=S
| IPO Proceeds, $M | $115.00M |
|---|---|
| IPO Date | Oct 20, 2020 |
| CEO | Bihua Chen |
| Left Lead | Jefferies |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24 months |
| IPO Sector | Healthcare ▶ |
| IPO Geography | Global |
| Target Company | MoonLake Immunotherapeutics AG |
| Deal Announced | Oct 4, 2021 |
| Deal Size, $M | $360.00M |
| Deal Sector | Healthcare |
| Deal Geography | Europe |
| SEC Filings |
www.sec.gov 
|
| Approval Vote | Mar 31, 2022 |
| Amendment Vote | TBD |
| Closing Date | Apr 5, 2022 |
Formerly HLXA
MLTX
| Price | $10.01 |
|---|---|
| Last closing price | $9.81 |
| H/L, today | $9.70 / $10.13 |
| H/L, 52-week | $7.05 / $63.40 |
| Volume, today | 2,178,477 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.